Multi-omics experiments allow researchers to make important discoveries in ways that have never before been possible. However, integrating these data into a broader biological context can be challenging and time consuming when using standard resources. At QIAGEN, we have introduced an innovative solution to this challenge: The market-leading QIAGEN Ingenuity Pathway Analysis (IPA) software integrated with our QIAGEN OmicSoft databases.